JMJD6 and malignant colon neoplasm: Nonetheless, the information is consistent with our observations that JMJD6 is a negative regulator of p53 and an important regulator for cell proliferation and tumorigenesis, supporting the pursuit of JMJD6 as a novel biomarker of colon cancer progression and a potential target for colon cancer intervention.